Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Pilot Study of Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event: Comparison With CHAMPS Results.

NCT00037115 is registered in ClinicalTrials.gov with MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00037115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Pilot Study of Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event: Comparison With CHAMPS Results.
Lead sponsor
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
Phase
Phase 4
Overall status
Withdrawn
Start date
May 31, 2002
Completion date
December 31, 2002
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

demyelinating disorders, multiple sclerosis, myelitis, neuritis, optic neuritis